University of Pittsburgh PITT HOME  |  FIND PEOPLE  |  CONTACT US  
 
Health Sciences @ Pitt   |    UPMC   |    HSLS   |    School of Medicine   |    Health Sciences Calendar   |    Our News & Events  
 
HOME
ABOUT US
FACULTY
CLINICAL TRAINEES
RESEARCH TRAINEES
ATTENTION ALUMNI
RESIDENCY PROGRAM
RESIDENT WEBSITE
CONFERENCES
EVENTS
CORNEA FELLOWSHIP PROGRAM
GLAUCOMA FELLOWSHIP PROGRAM
NEURO-OPHTHALMOLOGY FELLOWSHIP PROGRAM
ORBITAL, OCULOPLASTICS AND AESTHETIC SURGERY FELLOWSHIP
PEDIATRIC OPHTHALMOLOGY FELLOWSHIP PROGRAM
RETINA FELLOWSHIP PROGRAM
CLINICAL RESOURCES
VISUAL DIAGNOSTICS, IMAGING & LASERS
OPHTHALMOLOGY RESEARCH
RESEARCH LABORATORIES
CORE RESEARCH FACILITIES
GIVING & DEVELOPMENT
LECTURE SCHEDULE
LINKS
EMPLOYMENT OPPORTUNITIES
NEWS & AWARDS
Faculty
divider bar
 
16Kowalski.jpg Regis P. Kowalski, MS, M(ASCP)
Research Professor of Ophthalmology
Executive Director, Charles T. Campbell Ophthalmic Microbiology Laboratory
University of Pittsburgh School of Medicine

Eye & Ear Institute
203 Lothrop Street, Room 643
Pittsburgh, PA 15213
Phone: 412-647-7211


Faculty Research Interests
Personal Web Page
 
bullet point  Research Interests
a dividing bar
Charles T Campbell Microbiology Laboratory

 
bullet point  Education
a dividing bar
1972 – 1977 University of Pittsburgh, Pittsburgh, PA, 1977, Microbiology & Biophysics, BS

1980 – 1983 University of Pittsburgh, Pittsburgh, PA; 1983, Bioengineering, MS
 
bullet point  Academic Affiliation
a dividing bar
2013 to present Research Professor of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh PA

2010 to present Executive Director, The Charles T. Campbell Ophthalmic Microbiology, University of Pittsburgh School of Medicine, Pittsburgh PA
 
bullet point  Publications
a dividing bar
1. Hillenbrand ME, Thompson PP, Shanks MQ, Kowalski RP. Validation of PCR for the detection of Pseudomonas aeruginosa from corneal samples. Int J Ophthalmol 2011;4(3):262-268.

2. Eisley KM, Miller KV, Shanks RMQ, Lahr RM, Lathrop KL, Kowalski RP, Noecker RJ. Recurrent enterococcal endophthalmitis seeded by an intraocular lens biofilm. J Cat Refrac Surgery2011;37(7):1355-1359.

3. Wingard JB, Romanowski EG, Kowalski RP, Ling Y, Bilonick RA, Shanks RMQ. A novel cell-associated protection assay (CAPA) demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge. Antimicrobial Agents and Chemotherapy 2011;55(8):3788-3794.

4. Rarey K, Shanks RMQ, Romanowski EG, Mah FS, Gondaira F, Kowalski RP. Staphylococcus aureus from endophthalmitis are hospital-acquired based on PVL and antibiotic suscdeptibility testing. J Ocular Pharm Thera 2012;28(1):12-16.

5. Deschler EK, Thompson PP, Kowalski RP. Evaluation of the new OxyPlate anaerobic system for the isolation of ocular anaerobic bacteria. International J Ophthalmol 2012;5:

6. O’Toole GA, Wathier M, Zegans ME, Shanks RMQ, Kowalski RP, Grinstaff MW. Diphosphonium ionic liquids as broad spexctrum antimicrobial agents and their in vivo use to prevent ocular infections. Cornea 2012;31(7):810-6.

7. Yoder JS, Verani J, Heidman N, Kowalski RP (17 author). Cases of Acanthamoeba keratitis diagnosed following a multistate Acanthamoeba keratitis outbreak, 2007-2009. Ophthalmic Epidemiology 2012;19(4):221-225.

8. Shanks RMQ, Stella NA, Lahr RM, Wang S, Veverka TI, Kowalski RP, Liu X. (2012) Serratamolide is a hemolytic factor produced by Serratia marcescens. PLos One: 7(5) e36398. Doi:10.1371/journal.pone.0036398.

9. Kowalski RP, Kowalski TA, Shanks RMQ, Romanowski EG, Karenchak LM, Mah FS. In Vitro Comparison of Combination- and Mono-therapy for the Empiric and Optimal Coverage of Bacterial Keratitis Based on Incidence of Infection, Cornea 2013;32:830-834.

10. Kowalski RP, Romanowski EG, Shanks RMQ, Mah FS. The Comparison of Fluoroquinolones to Non-fluoroquinolone Antibacterial Agents for the Prevention of Endophthalmitis in a Rabbit Model. J Ocul Pharmacol Ther 2012;28:604-608.

11. Romanowski EG, Yates KA, O’Connor KE, Mah FS, Shanks RMQ, Kowalski RP. The evaluation of polyhexamethylene biguanide (PHMB) as a disinfectant for adenovirus. JAMA Ophthalmol 2013;131(4):495.

12. Kowalski RP. Perspective: Is Antibiotic Resistance a Problem in the Treatment of Ophthalmic Infections? Exp Rev Ophthalmol 2013:8(2):119-226.

13. Kowalski RP, Abdel Aziz S, Romanowski EG, Shanks RMQ, Raju LV. Development of a Practical Complete-Kill assay to Evaluate Anti-Acanthamoeba Drugs. JAMA Ophthalmol 2013;131(11):1459.

14. Kowalski RP, Margolis TP. Molecular diagnostics: Rigourous clinical validation requirements result in high reliability. EuroTimes 2013;18(5):29.

15. Kowalski RP, Karenchak LM, Elnyczky CM, Raju LV, Ismail N. The Validation of Nucleic Acid Amplification Testing (NAAT) (Gen-Probe® Aptima®) for Chlamydia trachomatis from Ocular Samples. Ophthalmology 2014 (submitted).

16. Elam AR, Kowalski TA, Romanowski EG, Kowalski RP. The origin of Staphylococcus aureus isolated from blepharitis based on panton-valentine leucocidin and antibiotic susceptibility testing. Journal of Ocular Diseases and Therapeutics 2014 (submitted)
 
 
  Top of page  |  Home  |  Contact Us Last Update 6/28/2017  
  © Office of the Senior Vice Chancellor for the Health Sciences, University of Pittsburgh. All rights reserved.